Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Zymeworks Inc.
Zymeworks Announces Participation in Upcoming Investor Conferences
August 11, 2026
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
June 15, 2026
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 21, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
May 21, 2026
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 8, 2026
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
April 25, 2026
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
April 22, 2026
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
April 17, 2026
1
2
Next Page
→